0001047469-05-002444.txt : 20120705 0001047469-05-002444.hdr.sgml : 20120704 20050204151719 ACCESSION NUMBER: 0001047469-05-002444 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050204 DATE AS OF CHANGE: 20050204 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOLECULAR DEVICES CORP CENTRAL INDEX KEY: 0001003113 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 942914362 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-44597 FILM NUMBER: 05576906 BUSINESS ADDRESS: STREET 1: 1311 ORLEANS DR CITY: SUNNYVALE STATE: CA ZIP: 94089 BUSINESS PHONE: 4087471700 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: H&Q HEALTHCARE INVESTORS CENTRAL INDEX KEY: 0000805267 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 046564285 STATE OF INCORPORATION: MA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 30 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6175740537 MAIL ADDRESS: STREET 1: 30 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 SC 13G/A 1 a2151096zsc13ga.txt SC 13G/A -------------------------- UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION -------------------------- OMB Number: 3235-0145 WASHINGTON, D.C. 20549 -------------------------- Expires: December 31, 2005 -------------------------- Estimated average burden SCHEDULE 13G hours per response...11 -------------------------- UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* Molecular Devices Corp. (formerly LJL Biosystems) -------------------------------------------------------------------------------- (Name of Issuer) Common -------------------------------------------------------------------------------- (Title of Class of Securities) 60851C107 -------------------------------------------------------- (CUSIP Number) 12/31/04 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: /X/ Rule 13d-1(b) / / Rule 13d-1(c) / / Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 60851C107 -------------- ------------------------------------------------------------------------------- 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only). Hambrecht & Quist Capital Management LLC 01-0628853 ------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / (b) /X/ ------------------------------------------------------------------------------- 3. SEC Use Only ------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Delaware ------------------------------------------------------------------------------- Number of Shares 5. Sole Voting Power Beneficially Owned by Each Reporting Person 0 With ---------------------------------------------------- 6. Shared Voting Power N/A ---------------------------------------------------- 7. Sole Dispositive Power N/A ---------------------------------------------------- 8. Shared Dispositive Power N/A ------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 0 ------------------------------------------------------------------------------- 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / ------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 0.0% ------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) IA ------------------------------------------------------------------------------- ITEM 1. (a) Name of Issuer Molecular Devices Corp. (formerly LJL Biosystems, Inc.) -------------------------------------------------------------------- (b) Address of Issuer's Principal Executive Offices 1311 Orleans Drive Sunnyvale, CA 94089 -------------------------------------------------------------------- ITEM 2. (a) Name of Person Filing Hambrecht & Quist Capital Management LLP -------------------------------------------------------------------- (b) Address of Principal Business Office or, if none, Residence 30 Rowes Wharf, Suite 430 Boston, MA 02110 -------------------------------------------------------------------- (c) Citizenship Delaware Corporation -------------------------------------------------------------------- (d) Title of Class of Securities Common Stock -------------------------------------------------------------------- (e) CUSIP Number 60851C107 -------------------------------------------------------------------- ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTIONS 240.13d-1(b) or 240.13d-2(b) or (c), CHECK WHETHER THE PERSON FILING IS A: (a) / / Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) / / Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) / / Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) /X/ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) / / An investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) / / An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) / / A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) / / A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) / / A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) / / Group, in accordance with Section 240.13d-1(b)(1)(ii)(J). ITEM 4. OWNERSHIP Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 0 -------------------------------------------------------------------- (b) Percent of Class: 0.0% -------------------------------------------------------------------- (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 0 ------------------------------------------------------------- (ii) Shared power to vote or to direct the vote N/A ------------------------------------------------------------- (iii) Sole power to dispose or to direct the disposition of N/A ------------------------------------------------------------- (iv) Shared power to dispose or to direct the disposition of N/A ------------------------------------------------------------- ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following /X/. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON N/A ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON N/A ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP N/A ITEM 9. NOTICE OF DISSOLUTION OF GROUP N/A ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 4, 2005 ----------------------------------------- Date /s/ Kimberley Carroll ----------------------------------------- Signature Kimberley Carroll/Vice President ----------------------------------------- Name/Title